Works matching DE "IMMUNO-Designed Molecules SA"

Phase II drug trial for malignant melanoma.

Published in:

European Journal of Cancer Care, 2003, v. 12, n. 1, p. 2, doi. 10.1046/j.1365-2354.2003.00379.x

Publication type:

Article